Microbot Medical Inc. short interest in 2022
In 2022, Microbot Medical Inc.'s disclosed short interest ran from 3.03% of shares outstanding on 28 Feb 2022 to 1.05% on 30 Dec 2022, a change of -1.98 percentage points. The year's high was 3.03% on 28 Feb 2022 and its low 1.05% on 30 Dec 2022, averaging 1.61% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.20 days on 31 Aug 2022. Full history: Microbot Medical Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 3.03% (28 Feb 2022)
- End of year
- 1.05% (30 Dec 2022)
- Change
- -1.98 pp
- High
- 3.03% (28 Feb 2022)
- Low
- 1.05% (30 Dec 2022)
- Average
- 1.61%
- Highest days to cover
- 17.20 (31 Aug 2022)
- SEC filings marked
- 4
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Feb 2022 | 3.03% | 4.59 | |
| 15 Mar 2022 | 2.57% | 4.95 | |
| 31 Mar 2022 | 2.15% | 5.00 | 10-K filed |
| 14 Apr 2022 | 1.81% | 5.79 | |
| 29 Apr 2022 | 1.71% | 6.90 | |
| 13 May 2022 | 1.66% | 5.97 | |
| 31 May 2022 | 1.67% | 8.58 | 10-Q filed |
| 15 Jun 2022 | 1.53% | 5.93 | |
| 30 Jun 2022 | 1.53% | 7.26 | |
| 15 Jul 2022 | 1.59% | 11.14 | |
| 29 Jul 2022 | 1.57% | 13.48 | |
| 15 Aug 2022 | 1.41% | 10.19 | 10-Q filed |
| 31 Aug 2022 | 1.34% | 17.20 | |
| 15 Sep 2022 | 1.37% | 7.31 | |
| 30 Sep 2022 | 1.36% | 6.70 | |
| 14 Oct 2022 | 1.34% | 13.33 | |
| 31 Oct 2022 | 1.36% | 6.01 | |
| 15 Nov 2022 | 1.27% | 5.10 | 10-Q filed |
| 30 Nov 2022 | 1.28% | 14.14 | |
| 15 Dec 2022 | 1.11% | 10.72 | |
| 30 Dec 2022 | 1.05% | 3.35 |
See also: Microbot Medical Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.